Centurion BioPharma Corporation

Jun 26, 2019

CytRx Corporation Highlights Patent Issued for New Aldoxorubicin Formulation

Mar 12, 2019

CytRx Corporation's Subsidiary, Centurion BioPharma Corporation's Albumin Companion Diagnostic (ACDx), Could Be The First To Personalize Medicine For Albumin-Based Drug Delivery Systems

Feb 13, 2019

CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR(TM) Technology Targeting Delivery Directly to the Tumor

Dec 21, 2018

CytRx Corporation Announces Conclusion of Pre-Clinical Phase for Its Albumin Binding Ultra High Potency LADR(TM) Drug Candidates and Accompanying Companion Diagnostic

Nov 28, 2018

CytRx Corporation to Present at the 11th Annual LD Micro Main Event

Oct 31, 2018

Key Emerging Oncology Trends By Big Pharma Strengthen CytRx's Rationally Designed, Targeted Therapies Pipeline

Sep 25, 2018

CytRx Corporation to Present at the 2018 MicroCap Conference

Jul 25, 2018

CytRx Announces Centurion BioPharma Corporation's Filing of a Provisional Patent Application

Jun 25, 2018

CytRx Corporation Joins Russell Microcap® Index